Asston Pharmaceuticals Ltd vs Sai Life Sciences Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Asston Pharmaceuticals Ltd is ₹ 80.9 as of 30 Apr 15:30 . The P/E Ratio of Asston Pharmaceuticals Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Sai Life Sciences Ltd changed from 93.4 on March 2025 to 93.4 on March 2025 . This represents a CAGR of 0.00% over 1 years The Market Cap of Asston Pharmaceuticals Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Sai Life Sciences Ltd changed from ₹ 15883 crore on March 2025 to ₹ 15883 crore on March 2025 . This represents a CAGR of 0.00% over 1 years The revenue of Asston Pharmaceuticals Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Sai Life Sciences Ltd for the Dec '25 is ₹ 564.84 crore as compare to the Sep '25 revenue of ₹ 552.8 crore. This represent the growth of 2.18% The ebitda of Asston Pharmaceuticals Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Sai Life Sciences Ltd for the Dec '25 is ₹ 187.94 crore as compare to the Sep '25 ebitda of ₹ 161.15 crore. This represent the growth of 16.62% The net profit of Asston Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Sai Life Sciences Ltd changed from ₹ -13.5 crore to ₹ 100.38 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of Asston Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Sai Life Sciences Ltd changed from 443.82 % on March 2022 to 0 % on March 2025 . This represents a CAGR of -100.00% over 4 years .

About Asston Pharmaceuticals Ltd

Asston Pharmaceuticals Limited was incorporated on 16th April 2019 as 'Asston Pharmaceutical Pvt.
Limited' to contract produce pharmaceutical products for export market.
Later on 1st April 2024, Company acquired Ferron Lifecare Private Limited, specializing into nutraceuticals business and produced nutraceutical products at their Ambarnath facility.
Ferron Lifecare Private Limited, incorporated on 30th January 2020.
Finally, 'Asston Pharmaceuticals Private Limited' was converted into a Public Limited Company in the name of 'Asston Pharmaceuticals Limited' on 29th August 2024 and received FDA approval for its Ambarnath facility on 2nd December 2024 to produce pharmaceutical products. Presently, Company is involved in the business of manufacturing and marketing of Tablets, Capsules, Oral Liquid, External Preparations (Ointment, Cream, Gel and Lotion) and Oral Powder (Sachet, Dry Syrup) etc.

About Sai Life Sciences Ltd

Sai Life Sciences Limited was originally incorporated as Sai Dru Syn Laboratories Limited' as a Public Limited Company, dated January 25, 1999, issued by the Registrar of Companies, Andhra Pradesh at Hyderabad.
The Company received the Certificate of Commencement of Business from Registrar of Companies, Andhra Pradesh on February 17, 1999.
Subsequently, the Company name was changed from Sai Dru Syn Laboratories Limited' to Sai Life Sciences Limited' dated December 16, 2003. Thereafter, the name of the Company was changed from Sai Life Sciences Limited' to Sai Advantium Pharma Limited' dated August 30, 2006 issued by the Registrar of Companies, Andhra Pradesh.
Subsequently, the Company name was changed from Sai Advantium Pharma Limited' to Sai Life Sciences Limited' and a fresh Certificate of Incorporation dated May 28, 2012 was issued by the Registrar of Companies, Andhra Pradesh at Hyderabad.

FAQs for the comparison of Asston Pharmaceuticals Ltd and Sai Life Sciences Ltd

Which company has a larger market capitalization, Asston Pharmaceuticals Ltd or Sai Life Sciences Ltd?

Market cap of Asston Pharmaceuticals Ltd is 68 Cr while Market cap of Sai Life Sciences Ltd is 22,668 Cr

What are the key factors driving the stock performance of Asston Pharmaceuticals Ltd and Sai Life Sciences Ltd?

The stock performance of Asston Pharmaceuticals Ltd and Sai Life Sciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Asston Pharmaceuticals Ltd and Sai Life Sciences Ltd?

As of May 4, 2026, the Asston Pharmaceuticals Ltd stock price is INR ₹80.9. On the other hand, Sai Life Sciences Ltd stock price is INR ₹1070.4.

How do dividend payouts of Asston Pharmaceuticals Ltd and Sai Life Sciences Ltd compare?

To compare the dividend payouts of Asston Pharmaceuticals Ltd and Sai Life Sciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.